Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Mar;40(3):381-4.
doi: 10.1111/j.1365-2222.2009.03450.x.

Drug-induced rhinitis

Affiliations
Review

Drug-induced rhinitis

M Varghese et al. Clin Exp Allergy. 2010 Mar.

Abstract

Background: Rhinitis is characterized by inflammation of the mucous membranes lining the nose and can be divided into two categories, allergic and non-allergic. Drug-induced is a type of non-allergic rhinitis.

Objective: A review of the literature was conducted. Very little is known about this topic and there are no publications to date solely devoted to drug-induced rhinitis.

Methods: A PubMed and Medline search was conducted using a combination of the keywords; drug, medication, rhinitis, congestion, rhinorrhea, sneezing, pruritus, vasomotor, reflex, neurogenic, allergic and non-allergic. Medications that were found in the search were then cross-referenced with the physicians desk reference and Epocrates. The final literature search was conducted in August 2009.

Results: Three categories of drug-induced rhinitis exist based on the mechanism of action. These include local inflammatory, neurogenic and idiopathic types. Rhinitis medicamentosa, a form of drug-induced rhinitis, has unique characteristics.

Conclusion: When possible, the offending medication should be discontinued or substituted. Although there are no established treatment recommendations for drug-induced rhinitis other than avoidance, clinical experience suggests that it would be reasonable to initiate use of an intranasal corticosteroid spray to treat symptomatically. The addition of an intranasal antihistamine in combination with use of an intranasal corticosteroid may be considered as step-up therapy if the intranasal corticosteroid alone is not effective.

PubMed Disclaimer

Similar articles

Cited by

  • Intranasal corticosteroids for non-allergic rhinitis.
    Segboer C, Gevorgyan A, Avdeeva K, Chusakul S, Kanjanaumporn J, Aeumjaturapat S, Reeskamp LF, Snidvongs K, Fokkens W. Segboer C, et al. Cochrane Database Syst Rev. 2019 Nov 2;2019(11):CD010592. doi: 10.1002/14651858.CD010592.pub2. Cochrane Database Syst Rev. 2019. PMID: 31677153 Free PMC article.
  • The peculiarities of different types of chronic rhinitis in children and adolescents in Kazakhstan.
    Zhumambayeva S, Rozenson R, Morenko M, Shaidarov M, Zatonskikh V, Kazangapova A, Zhumadilova Z, Zhumambayeva R. Zhumambayeva S, et al. Iran J Public Health. 2013 Apr 1;42(4):374-9. Print 2013. Iran J Public Health. 2013. PMID: 23785676 Free PMC article.
  • Pharmacists' Attitudes Towards Long-Term Use of Nasal Decongestants: A Cross-Sectional Study.
    Mokhatrish MM, Almatrafi SD, Aldrees TM, Aldriweesh TA, AlGhamdi FM, Al-Dosary AS, Alhumaydani NK, Aldakkan OZ, Alrudian N, Ali AH. Mokhatrish MM, et al. J Multidiscip Healthc. 2024 Mar 13;17:1079-1090. doi: 10.2147/JMDH.S451835. eCollection 2024. J Multidiscip Healthc. 2024. PMID: 38505655 Free PMC article.
  • Chronic bronchitis without airflow obstruction, asthma and rhinitis are differently associated with cardiovascular risk factors and diseases.
    Ferrari M, Piccinno E, Marcon A, Marchetti P, Cazzoletti L, Pirina P, Battaglia S, Grosso A, Squillacioti G, Antonicelli L, Verlato G, Pesce G. Ferrari M, et al. PLoS One. 2019 Nov 7;14(11):e0224999. doi: 10.1371/journal.pone.0224999. eCollection 2019. PLoS One. 2019. PMID: 31697758 Free PMC article.
  • International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.
    Wise SK, Lin SY, Toskala E, Orlandi RR, Akdis CA, Alt JA, Azar A, Baroody FM, Bachert C, Canonica GW, Chacko T, Cingi C, Ciprandi G, Corey J, Cox LS, Creticos PS, Custovic A, Damask C, DeConde A, DelGaudio JM, Ebert CS, Eloy JA, Flanagan CE, Fokkens WJ, Franzese C, Gosepath J, Halderman A, Hamilton RG, Hoffman HJ, Hohlfeld JM, Houser SM, Hwang PH, Incorvaia C, Jarvis D, Khalid AN, Kilpeläinen M, Kingdom TT, Krouse H, Larenas-Linnemann D, Laury AM, Lee SE, Levy JM, Luong AU, Marple BF, McCoul ED, McMains KC, Melén E, Mims JW, Moscato G, Mullol J, Nelson HS, Patadia M, Pawankar R, Pfaar O, Platt MP, Reisacher W, Rondón C, Rudmik L, Ryan M, Sastre J, Schlosser RJ, Settipane RA, Sharma HP, Sheikh A, Smith TL, Tantilipikorn P, Tversky JR, Veling MC, Wang Y, Westman M, Wickman M, Zacharek M. Wise SK, et al. Int Forum Allergy Rhinol. 2018 Feb;8(2):108-352. doi: 10.1002/alr.22073. Int Forum Allergy Rhinol. 2018. PMID: 29438602 Free PMC article.

Substances

LinkOut - more resources